Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.
|Number of pages||1|
|Publication status||Published - 16 Nov 2003|
|Event||45th Annual Meeting of the American-Society-of-Hematology - San Diego, United States|
Duration: 6 Dec 2003 → 9 Dec 2003
- ph+ cell line
Holyoake, T. L., Allan, E. K., Mountford, J. C., Richmond, L., Harrison, S. J., Elliott, M. A., & Jorgensen, H. G. (2003). Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. Blood, 102(11), 654A-654A. .